Foghorn Therapeutics Inc. - FHTX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Chief Financial Officer | A | A | 400,000.0 | 5.75 | 2,300,000.0 | 400,000.0 | View | |
| Feb 06, 2026 | Chief Executive Officer | A | A | 1,075,000.0 | 5.23 | 5,622,250.0 | 1,075,000.0 | View | |
| Feb 02, 2026 | Chief People Officer | A | A | 230,000.0 | 5.71 | 1,313,300.0 | 230,000.0 | View | |
| Feb 02, 2026 | Chief Legal Officer | A | A | 295,000.0 | 5.71 | 1,684,450.0 | 295,000.0 | View | |
| Feb 02, 2026 | Chief Medical Officer | A | A | 300,000.0 | 5.71 | 1,713,000.0 | 300,000.0 | View | |
| Feb 02, 2026 | Chief Business Officer | A | A | 165,000.0 | 5.71 | 942,150.0 | 165,000.0 | View | |
| Feb 02, 2026 | Chief Scientific Officer | A | A | 300,000.0 | 5.71 | 1,713,000.0 | 300,000.0 | View | |
| Jan 15, 2026 | — | A | A | 1,117,734.0 | — | — | 1,117,734.0 | View | |
| Jan 15, 2026 | — | A | A | 1,117,734.0 | — | — | 1,117,734.0 | View | |
| Jan 15, 2026 | — | A | A | 2,235,468.0 | 6.7099 | 14,999,766.73 | 2,235,468.0 | View |